Vahram Haroutunian, PhD Email Vahram Haroutunian
-
- Positions
- PROFESSOR | Psychiatry
- PROFESSOR | Neuroscience
-
- Language
- English
Research Topic
Alzheimer's Disease, Glutamate (NMDA & AMPA) Receptors, Myelination, Neurotransmitters, RNA, Schizophrenia
Multi-Disciplinary Training Area
Neuroscience [NEU]
Education
PhD, Kent State University
, Princeton University
Language
English
Haroutunian V, Katsel P, Schmeidler J. Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. Neurobiology of Aging 2009; 30(4): 561-573.
Hoffman LB, Schmeidler J, Lesser G, Beeri MS, Purohit DP, Grossman HT. Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology 2009; 72(20): 1720-1726.
Katsel P, Tan W, Haroutunian V. Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals. PloS ONE 2009; 4(10): 7642.
Beeri MS, Schmeidler J, Silverman J, Gandy S, Wysocki M, Hannigan CM. Insulin in combination with other diabetes medication is associated with lower Alzheimer's neuropathology. Neurology 2008; 71: 750-757.
Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 2008; 65(9): 1211-1217.
Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB. Abnormal Indices of Cell Cycle Activity in Schizophrenia and their Potential Association with Oligodendrocytes. Neuropsychopharmacology 2008; 33: 2993-3009.
Beeri MS, Rapp M, Silverman JM, Schmeidler J, Grossman HT, Fallon JT. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers - Reply from the authors. Neurology 2007; 68(6): 471.
Haroutunian V, Davies P, Vianna C, Buxbaum JD, Purohit DP. Tau protein abnormalities associated with the progression of alzheimer disease type dementia. Neurobiology of Aging 2007; 28(1): 1-7.
Beeri MS, Rapp M, Silverman JM, Schmeidler J, Grossman H, Fallon JT. Coronary artery disease is associated with Alzheimer's disease neuropathology in APOE 4 carriers. Neurology 2006; 66(9): 1399-1404.
Byne W, Tatusov A, Kidkardnee S, Yiannoulos G, Haroutunian V. Schizophrenia-associated reduction of oligodendrocytes in anterior thalamic nucleus. Schizo Res 2006; 85(1-3): 245-253.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Haroutunian did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.